Covid 19 Clinical Trials

CovidResearchTrials by Shray Alag

drug1216: Sample collection

Hydroxychloroquine (88)

Azithromycin (28)

Placebo oral tablet (24)

Tocilizumab (20)

Remdesivir (14)

Standard of care (13)

Convalescent Plasma (11)

Favipiravir (11)

Lopinavir/ritonavir (11)

Standard of Care (11)

Convalescent plasma (10)

Hydroxychloroquine Sulfate (10)

No intervention (10)

Questionnaire (10)

Methylprednisolone (9)

Chloroquine (8)

Ruxolitinib (7)

Baricitinib (5)

Blood sample (5)

Oseltamivir (5)

Standard care (5)

Ascorbic Acid (4)

COVID-19 Convalescent Plasma (4)

Camostat Mesilate (4)

Lung ultrasound (4)

Mepolizumab (4)

Nitazoxanide (4)

Telerehabilitation (4)

anti-SARS-CoV-2 convalescent plasma (4)

blood sampling (4)

convalescent plasma (4)

BCG Vaccine (3)

Blood sampling (3)

COVID-19 RT-PCR (3)

COVID-19 convalescent plasma (3)

Control group (3)

Data collection (3)

Doxycycline (3)

Hydrocortisone (3)

Hydroxychloroquine (HCQ) (3)

Hydroxychloroquine Sulfate 200 MG [Plaquenil] (3)

Interferon Beta-1A (3)

Interferon Beta-1B (3)

Lopinavir / Ritonavir (3)

Mesenchymal Stromal Cells (3)

Nasopharyngeal swab (3)

Nitric Oxide (3)

Nitric Oxide Gas (3)

Placebo oral capsule (3)

Povidone-Iodine (3)

SARS-CoV-2 convalescent plasma (3)

Sargramostim (3)

SnPP Protoporphyrin plus Sunlight exposure (3)

Standard treatment (3)

Suspension of heat killed (autoclaved) Mycobacterium w (3)

Telemedicine (3)

blood sample (3)

hydroxychloroquine (3)

no intervention (3)

observational (3)

standard therapy (3)

200 mg EIDD-2801 (2)

ACE inhibitor (2)

Abidol hydrochloride (2)

Acalabrutinib (2)

Azithromycin Tablets (2)

BCG vaccine (2)

Baricitinib Oral Tablet (2)

Bevacizumab Injection (2)

Blood tests (2)

COVID-19 Serology (2)

ChAdOx1 MERS (2)

ChAdOx1 nCoV-19 (2)

Chloroquine Sulfate (2)

Chloroquine or Hydroxychloroquine (2)

Chloroquine phosphate (2)

Clazakizumab (2)

Clopidogrel (2)

Convalescent Plasma (anti-SARS-CoV-2 plasma) (2)

Data Collection (2)

Data record (2)

Dexamethasone (2)

Dexamethasone injection (2)

Dornase Alfa Inhalation Solution [Pulmozyme] (2)

Echocardiography (2)

Electronic questionnaire (2)

Human immunoglobulin (2)

Hydroxychloroquine + Azithromycin (2)

Hydroxychloroquine + azithromycin (2)

Hydroxychloroquine - Weekly Dosing (2)

Hydroxychloroquine 200 Mg Oral Tablet (2)

Hydroxychloroquine Sulfate 200 MG (2)

Hydroxychloroquine Sulfate Loading Dose (2)

Hydroxychloroquine Sulfate Regular dose (2)

Hydroxychloroquine and Azithromycin (2)

Hydroxychloroquine sulfate (2)

Interleukin-7 (2)

Itraconazole (2)

L-ascorbic acid (2)

Leronlimab (700mg) (2)

Lopinavir-Ritonavir (2)

Mavrilimumab (2)

Methylprednisolone Sodium Succinate (2)

NORS (Nitric Oxide Releasing Solution) (2)

Niclosamide (2)

No Intervention (2)

Normal saline (2)

Online Survey (2)

Online questionnaire (2)

PUL-042 Inhalation Solution (2)

Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances (2)

Peginterferon Lambda-1A (2)

Peripheral blood draw (2)

Placebo to match filgotinib (2)

Povidone-Iodine Nasal Spray and Gargle (2)

Prone position (2)

Prone positioning (2)

Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (2)

Remdesivir placebo (2)

Remestemcel-L (2)

Rivaroxaban (2)

Routine care for COVID-19 patients (2)

Ruxolitinib Oral Tablet (2)

Saliva collection (2)

Serological test (2)

Single Dose of Hydroxychloroquine (2)

SivoMixx (200 billion) (2)

Standard Care (2)

Standard of Care (SOC) (2)

Supportive Care (2)

Taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling. (2)

Telmisartan (2)

Tocilizumab (TCZ) (2)

Unfractionated heparin (2)

Zinc Sulfate (2)

basic treatment (2)

blood donation SMS (2)

oxygen therapy (2)

pregnant women with laboratory-confirmed 2019-n-CoV (2)

retrospective analysis (2)

self-administered questionnaire (2)

standard care (2)

vv-ECMO + cytokine adsorption (Cytosorb adsorber) (2)

vv-ECMO only (no cytokine adsorption) (2)

"Calm" is a mindfulness meditation mobile app (1)

(Standard of Care) SoC (1)

- Synthetic anti-malarial drugs (1)

0.9% Sodium-chloride (1)

0.9% sodium chloride (normal saline) (1)

100 mg/mL Virazole (1)

14C-lazertinib (1)

18F-αvβ6-BP (1)

1: Naproxen (1)

1: Prone positioning (1)

1: Usual practice (1)

1: discontinuation of RAS blocker therapy (1)

2019-nCoV PCR (1)

2: No instruction regarding positioning (1)

2: Placebo Comparator (1)

2: Standard of care (1)

2: Usual practice + SYMBICORT RAPIHALER (1)

2: continuation of RAS blocker therapy (1)

2D Telemedicine (1)

300 mg EIDD-2801 (1)

35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (cured Patients) (1)

35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (hospitalized Patients ) (1)

3D Telemedicine (1)

40ml blood sample (1)

50 mg/mL Virazole (1)

ACE inhibitor, angiotensin receptor blocker (1)

ASC09/ritonavir group (1)

ASC09F+Oseltamivir (1)

ATYR1923 1 mg/kg (1)

ATYR1923 3 mg/kg (1)

AV-COVID-19 (1)

Abdominal ultrasound (1)

Abidol Hydrochloride combined with Interferon atomization (1)

Acacia Senegal (1)

Acetylsalicylic acid (1)

Active PBMT/sMF (1)

Additional biological samples (1)

Aerosol-reducing Mask (1)

Aerosolized 13 cis retinoic acid (1)

Aerosolized All trans retinoic acid (1)

Aerosolized Isotretinoin plus Tamoxifen (1)

Airway pressure release ventilation (1)

Albuterol - Control (1)

Albuterol - Experimental (1)

Alferon LDO (1)

Allogeneic NK transfer (1)

Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells (1)

Allogenic pooled olfactory mucosa-derived mesenchymal stem cells (1)

Alteplase 100 MG [Activase] (1)

Alteplase 50 MG [Activase] (1)

Aluminum hydroxide (1)

Aluminum hydroxide adjuvant (Alhydrogel®) (1)

Amoxicillin-clavulanate (1)

Anakinra Prefilled Syringe (1)

Anakinra alone (stages 2b/3) (1)

Anakinra and Ruxolitinib (overcome stage 3) (1)

Angiography (1)

Angiotensin 1-7 (1)

Angiotensin II (1)

Angiotensin Receptor Blockers (1)

Angiotensin receptor blocker (1)

Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB) (1)

Anluohuaxian (1)

Anti- SARS-CoV-2 Plasma (1)

Anti-COVID-19 human immunoglobulin (1)

Anti-SARS-CoV-2 Human Convalescent Plasma (1)

Anti-SARS-CoV2 Serology (1)

Anti-Sars-CoV-2 Convalescent Plasma (1)

Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients (1)

Anti-coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients (1)

Antibody-Rich Plasma from COVID-19 recovered patients (1)

Any drug used to treat Covid-19 (1)

Apo-Hydroxychloroquine (1)

Apple Watch Series 5 (1)

Arbidol Hydrochloride Granules (1)

Artemisinin / Artesunate (1)

Ascorbic Acid and Zinc Gluconate (1)

Aspirin 100mg (1)

Aspirin 75mg (1)

Aspirin 81 mg (1)

Assembled mask (1)

Assessment of Dietary Changes in Adults in the Quarantine (1)

Assessment of cardiovascular diseases and cardiovascular risk factors (1)

Assessment of postnatal depression using the the Edinburgh questionnaire between 4 and 6 weeks after delivery (1)

Assessment of ventilator-associated pneumonia criteria (1)

Association of diltiazem and niclosamide (1)

Atorvastatin (1)

Atorvastatin 40mg (1)

Attention Bias Modification (ABM) (1)

Auditory Evoked Potentials (AEP) (1)

Auricular neuromodulation (1)

Auto-questionnaires (patients co infected HIV Sras-CoV-2) (1)

Autologous Adipose MSC's (1)

Automated oxygen administration - FreeO2 (1)

Aviptadil (VIP) (1)

Aviptadil by intravenous infusion + standard of care (1)

Awake Prone Positioning (1)

Awake Proning (1)

Awake proning (1)

Ayurvedic Kadha (1)

Azacitidine (1)

Azithromycin (Azithro) (1)

Azithromycin 250 MG (1)

Azithromycin 250 MG Oral Capsule (1)

Azithromycin 500 milligram (mg) oral Tablet (1)

Azithromycin 500Mg Oral Tablet (1)

Azithromycin Capsule (1)

Azithromycin and hydroxychloroquine (1)

Azithromycin with amoxicillin/clavulanate (1)

Açaí palm berry extract - natural product (1)

BAT + Calcifediol (1)

BCG-Denmark (1)

BIOMARKERS IN THE LONG TERM IMPACT OF CORONAVIRUS INFECTION IN THE CARDIORRESPIRATORY SYSTEM (1)

BM-Allo.MSC (1)

BVRS-GamVac (1)

BVRS-GamVac-Combi (1)

Bacille Calmette-Guérin (BCG) (1)

Bacterial species isolated (1)

Baricitinib (janus kinase inhibitor) (1)

Baricitinib 4 MG Oral Tablet (1)

Barrier box (1)

Bedside lung ultrasound (1)

Berzosertib (1)

Best Available Therapy (1)

Best Practice (1)

Best Supportive Care (1)

Best standard of care (1)

Bevacizumab (1)

BioMedomics COVID-19 IgM-IgG Rapid Test (1)

Biological Sample Collection (1)

Biological collection (patients co infected HIV Sras-CoV-2) (1)

Biological sample and clinical data collection (1)

Biological sample collection (1)

Biological samples specific to research (1)

Biological sampling (1)

Biological test (1)

Biological/Vaccine: Angiotensin peptide (1-7) derived plasma (1)

Biological: COVID-19 convalescent plasma (1)

Biological: mRNA-1273: 100 mcg (1)

Biological: mRNA-1273: 50 mcg (1)

Biomarkers expression (1)

Biospecimen Collection (1)

Biospecimen collection (1)

Blink and Masseter Inhibitory Reflex (1)

Blood Transfusion (1)

Blood and derivatives. (1)

Blood collection (1)

Blood collection on admission and longitudinally (1)

Blood collection on their first consultation and 10 to 14 days later (1)

Blood donation from convalescent donor (1)

Blood plasma (1)

Blood sample and data record (1)

Blood sample collection (1)

Blood sample for serology to measure past infection with SARS-CoV-2 (1)

Blood sample for whole genome sequencing (1)

Blood samples (1)

Blood samples (collection of 5 mL of blood in a dry tube) (1)

Blood samples collection (1)

Bone Marrow Harvest (1)

Breath test (1)

Brief Psychiatric Rating Scale (1)

Brief cognitive behavioural therapy (1)

Brief educational video (1)

Bromhexine Hydrochloride (1)

Bromhexine Hydrochloride Tablets (1)

Bromhexine Oral Tablet and/or hydroxychloroquine tablet (1)

Budesonide Nasal (1)

Budesonide dry powder inhaler (1)

C-reactive protein (1)

CAG length <24 (1)

CAG length >=24 (1)

CAP-1002 Allogeneic Cardiosphere-Derived Cells (1)

CELLECTRA® 2000 (1)

CFTR Modulators (1)

CHLORPROMAZINE (CPZ) (1)

CLIA of IgG and IgM against SARS-Cov-2 (1)

CM4620-Injectable Emulsion (1)

COM-COVID anonimous survey (1)

CONVALESCENT PLASMA (1)

COPAN swabbing and blood sample collection (1)

COVID 19 Diagnostic Test (1)

COVID 19 diagnostic test by PCR (1)

COVID Convalescent Plasma (1)

COVID positive via testing (1)

COVID-19 IgM/IgG Rapid Testing, mobile device image capture and telemedicine support (1)

COVID-19 PCR and Serology (1)

COVID-19 Pandemic (1)

COVID-19 Pneumonia (1)

COVID-19 Specific T Cell derived exosomes (CSTC-Exo) (1)

COVID-19 barrier box (1)

COVID-19 convalescent hyperimmune plasma (1)

COVID-19 diagnostic test (1)

COVID-19 exposure (1)

COVID-19 infection (1)

COVID-19 pandemic (1)

COVID-19 patients (1)

COVID-19 positive via testing (1)

COVID-19 swap test PCR (1)

COVID-19 test, polymerase chain reaction for SARS-CoV-2 (1)

COVID-19+ observational (1)

COVID-surgRES questionaire (1)

COVSurf Drug Delivery System (1)

Calcium Channel Blockers (1)

Calm Meditation App (1)

Cambridge Validated Viral Detection Method (1)

Canakinumab (1)

Canakinumab 150 MG/ML [Ilaris] (1)

Canakinumab Injection 300mg (1)

Canakinumab Injection 600mg (1)

Candesartan (1)

Capillary and salivary sampling (1)

Carboplatin (1)

Cardiopulmonary resuscitation (1)

Ceftaroline (1)

Ceftriaxone (1)

Cell therapy protocol 1 (1)

Cell therapy protocol 2 (1)

Cellectra 2000 Electroporation (1)

Cellular response (1)

Centricyte 1000 (1)

ChAdOx1 nCoV-19 + boost (1)

ChAdOx1 nCoV-19 boost (1)

ChAdox1 n-CoV vaccine low dose (1)

Chat-based instant messaging support (1)

Chemotherapy (1)

Chest computed tomography (CT) (1)

Chinese Herbal Medicine (1)

Chlorhexidine Gluconate (1)

Chloroquine Diphosphate (1)

Chloroquine analog (GNS651) (1)

Chloroquine diphosphate (1)

Chlorpromazine Injection (1)

Ciclesonide (1)

Ciclesonide 160Mcg Inhaler (1)

Ciclesonide Inhalation Aerosol (1)

Ciclesonide Metered Dose Inhaler [Alvesco] (1)

Clarithromycin (1)

Clazakizumab 12.5 mg (1)

Clazakizumab 25 mg (1)

Clinical Examination (1)

Clinical data (1)

Clinical diagnosis of COVID-19 by a health care professional (1)

Clinical examination (1)

Clinical interview (1)

CloSYS mouthwash (1)

Clopidogrel 75mg (1)

Colchicine 1 MG Oral Tablet (1)

Colchicine Tablets (1)

Colchicine plus symptomatic treatment (paracetamol) (1)

ColdZyme® mouth spray (1)

Collection of Biological Samples (1)

Collection of blood samples in order to create a biocollection (1)

Collection of samples (1)

Colorectal resection (1)

Combination of Lopinavir /Ritonavir and Interferon beta-1b (1)

Combined use of a respiratory broad panel multiplex PCR and procalcitonin (1)

Complement dosage (1)

Comprehensive treatment (1)

Conestat alfa (1)

Connor-Davidson Resilience Scale 10 items (CD-RISC 10) (1)

Continuation of ACEi/ARB (1)

Continuation of ARB/ACEI (1)

Continuous Positive Airway Pressure (1)

Continuous renal replacement therapy (1)

Control (albumin 5%) (1)

Control arm (1)

Control swab (1)

Convalescent COVID 19 Plasma (1)

Convalescent Plasma 1 Unit (1)

Convalescent Plasma 2 Units (1)

Convalescent Plasma Transfusion (1)

Convalescent Plasma from COVID-19 donors (1)

Convalescent Plasma of patients with COVID-19 (1)

Convalescent SARS COVID-19 plasma (1)

Convalescent Serum (1)

Convalescent anti-SARS-CoV-2 plasma (1)

Convalescent plasma (CP) (1)

Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) (1)

Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and Traditional Chinese Medicines (TCMs) granules (1)

Conventional treatment (1)

Coping strategies video (1)

CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test (1)

Coronavirus Disease 2019 (1)

Corticosteroid (1)

Corticosteroid injection (1)

Covid-19 + patients (1)

Covid-19 Antibody testing (IgG and IgM) (1)

Covid-19 Rapid Test Kit (RAPG-COV-019) (1)

Covid-19 presto test (1)

Covid-19 swab PCR test (1)

Crest Pro-Health Multi-Protection mouthwash (1)

Crisis intervention therapy (1)

Cross-sectional observational study (1)

Cyclosporine (1)

Cytokine Adsorption (1)

Cytokines dosage (1)

Cytokines measurement (1)

DAS181 COVID-19 (1)

Danoprevir+Ritonavir (1)

Dapagliflozin 10 MG (1)

Darunavir and Cobicistat (1)

Data Collection: Clinical Care Assessments (1)

Data collection and rhinopharyngeal swab (1)

Data collection up to 1 year (1)

Data registry (1)

Data research, database analysis (1)

Ddrops® products, 50,000 IU, Oral (1)

Defibrotide 25 mg/kg 24 hours continuous infusion for 15 days (1)

Defibrotide Injection (1)

Delayed diagnostics Anyplex TMII RV16 Detection (1)

Dental pulp mesenchymal stem cells (1)

Depression, Anxiety and Stress Scale (1)

Description of groups caracteristics (1)

Desferal 500 MG Injection (1)

Detection of anti-COVID-19 antibody level (1)

Determination of physical activity, quality of life, stress levels of isolated people at home with the danger of coronavirus. (1)

Dexamethasone and Hydroxychloroquine (1)

Dexmedetomidine Injectable Product (1)

Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta (1)

Diagnostic examination for venous thromboembolism (1)

Diagnostic test (1)

Dialyzable Leukocyte Extract (1)

Digital intervention (1)

Dipyridamole 100 Milligram(mg) (1)

Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally (1)

Discontinuation of ACEi/ARB (1)

Discontinuation of ARB/ACEI (1)

Distilled water (1)

Dociparastat sodium (1)

Doppler Echo (1)

Dornase Alfa (1)

Dornase Alfa Inhalation Solution (1)

Dose of Tinzaparin or Dalteparin (1)

Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment (1)

Drug: Isotretinoin plus Tamoxifen (1)

Duodenal biopsy (1)

Duplex ultrasound and Computed Tomography Angiography (1)

EUROIMMUN assay (1)

Echo-Doppler (1)

Education sessions (1)

Eicosapentaenoic acid gastro-resistant capsules (1)

Ejaculated semen sample (1)

Elective Cancer Surgery (1)

Electric pad for human external pain therapy (1)

Electrocardiogram, telemetry, echocardiogram, laboratory values (1)

Elisa-test for IgM and IgG to SARS-CoV-2 (1)

Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet (1)

Emtricitabine/tenofovir disoproxil (1)

End tidal breath sample (1)

Endoscopic management according to standard of care (1)

Enoxaparin 1 mg/kg (1)

Enoxaparin 40 Mg/0.4 mL Injectable Solution (1)

Enoxaparin 40Mg/0.4Ml Inj Syringe 0.4Ml (1)

Enoxaparin Prefilled Syringe [Lovenox] (1)

Enoxaparin Prophylactic Dose (1)

Enoxaparin sodium (1)

Enoxaparin/Lovenox Intermediate Dose (1)

Enriched Survey Feedback (1)

Environmental Decontamination (1)

Equipment with smartwatch throughout hospital stay on the general ward (1)

Essential oils (1)

Evaluation of the epidemiological characteristics of coronavirus infection (SARS-CoV-2) (1)

Examinations for the research: (1)

Examine the impact of COVID-19 during pregnancy (1)

Exercise brochure (1)

Exercise capacity (1)

Exercise physiology (1)

Experimental drug (1)

Experimental: Questionnaire without precaution information (1)

Exposed to the novel coronavirus disease 2019 (1)

Exposure (not intervention) - SARS-CoV-2 infection (1)

Exposure to the Dutch measures due to the Covid-19 pandemic. (1)

Exposure to the SARS-CoV-2 and its consequences (1)

Extra blood sample (1)

Extracorporeal Membrane Oxygenation (1)

Favipiravir (3200 mg + 1200 mg) (1)

Favipiravir (3200 mg + 1200 mg) combined with Azithromycin (1)

Favipiravir (3200 mg + 1200 mg) combined with Hydroxychloroquine (1)

Favipiravir (3600 mg + 1600 mg) (1)

Favipiravir + Standard of Care (1)

Favipiravir Combined With Tocilizumab (1)

Favipiravir and Hydroxychloroquine (1)

Favipiravir tablets (1)

Fibrin generation markers assays (1)

File Scanning (1)

File scanning (1)

FilmArray Pneumonia (1)

Fingolimod 0.5 mg (1)

Five-days oseltamivir (1)

Fixed-duration Hydrocortisone (1)

Fixed-duration higher dose Hydrocortisone (1)

Fluvoxamine (1)

Follow-up at 14 days (1)

Fondapariniux (1)

Fondaparinux (1)

GAD-7 (7-item Generalized Anxiety Disorder) (1)

GO2 PEEP MOUTHPIECE (1)

Galidesivir (1)

Gamification (1)

Ganovo+ritonavir+/-Interferon nebulization (1)

Garadacimab, Factor XIIa Antagonist Monoclonal Antibody (1)

Gargle/Mouthwash (1)

Gastrointestinal endoscopy (1)

General Public cohort (1)

General health education (1)

Global Longitudinal Strain (1)

Glucose tablets (1)

Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed (1)

Group 2: control group with enoxaparin 40mg/d (1)

Group A HCQ (1)

Group B Control (1)

Guided online support program (1)

HCQ & AZ vs HCQ+SIR (1)

HCQ + Intravenous Famotidine (1)

HCQ + Placebo (1)

HOME-CoV rule implementation (1)

Halo Oral Spray (1)

Halo Placebo (1)

Health Care Worker Survey (1)

Health-related quality of life (1)

Helmet CPAP (1)

Helmet Continuous Positive Airway Pressure (CPAP) (1)

Helmet non-invasive ventilation (NIV) (1)

Heparin Infusion (1)

Hidroxicloroquina (1)

Hidroxicloroquine (1)

High Flow Nasal Oxygen (HFNO) (1)

High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule (1)

High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule (1)

High nitrite/NDMA meals (1)

High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma (1)

High-Titer COVID-19 Convalescent Plasma (HT-CCP) (1)

High-dose chloroquine (1)

Hospital anxiety and depression scale (1)

Huaier Granule (1)

Human Biological samples (1)

Human biological samples (1)

Human umbilical cord derived CD362 enriched MSCs (1)

Humanistic Care (1)

Hydoxychloroquine or Chloroquine (1)

Hydrogen Oxygen Generator with Nebulizer (1)

Hydroxychloroquine (placebo) (1)

Hydroxychloroquine + Placebo (1)

Hydroxychloroquine + azithromycin + / - tocilizumab (1)

Hydroxychloroquine + lopinavir/ritonavir (1)

Hydroxychloroquine + placebo (1)

Hydroxychloroquine - Daily Dosing (1)

Hydroxychloroquine - Daily dosing (1)

Hydroxychloroquine Only Product in Oral Dose Form (1)

Hydroxychloroquine Oral Product (1)

Hydroxychloroquine Pre-Exposure Prophylaxis (1)

Hydroxychloroquine SAR321068 (1)

Hydroxychloroquine Sulfate (HCQ) (1)

Hydroxychloroquine Sulfate + Azithromycin (1)

Hydroxychloroquine Sulfate + Azythromycin (1)

Hydroxychloroquine Sulfate 200 milligram (mg) Tab (1)

Hydroxychloroquine Sulfate 400 mg twice a day (1)

Hydroxychloroquine Sulfate 600 mg once a day (1)

Hydroxychloroquine Sulfate 600 mg twice a day (1)

Hydroxychloroquine Sulfate Tablets (1)

Hydroxychloroquine Sulfate Tablets plus Lopinavir/ Ritonavir Oral Tablets (1)

Hydroxychloroquine and Ivermectin (1)

Hydroxychloroquine and azithromycin treatment (1)

Hydroxychloroquine and azithromycin treatment arm. (1)

Hydroxychloroquine as post exposure prophylaxis (1)

Hydroxychloroquine combined with Azithromycin (1)

Hydroxychloroquine in combination of Azithromycin (1)

Hydroxychloroquine plus Nitazoxanide (1)

Hydroxychloroquine plus standard preventive measures (1)

Hydroxychloroquine sulfate &Azithromycin (1)

Hydroxychloroquine, Azithromycin (1)

Hydroxychloroquine, Clindamycin (1)

Hydroxychloroquine, Clindamycin, Primaquine - high dose. (1)

Hydroxychloroquine, Clindamycin, Primaquine - low dose. (1)

Hydroxychloroquine, Doxycycline (1)

Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy) (1)

Hyperbaric Chamber (1)

Hyperbaric oxygen (1)

Hyperbaric oxygen therapy (1)

Hyperbaric oxygen treatment (HBOT) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device) (1)

Hyperimmune plasma (1)

IC14, a monoclonal antibody against CD14 (1)

ICU treatment (1)

ID NOW vs. Accula (1)

INC424 / Ruxolitinib (1)

IV Deployment Of cSVF In Sterile Normal Saline IV Solution (1)

IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care. (1)

Icosapent ethyl (1)

Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus (1)

IgM and IgG diagnostic kits to SARS-CoV-2 (1)

Imaging by thoracic scanner (1)

Imaging of the lungs (1)

Imatinib tablets (1)

Immunoglobulin of cured patients (1)

Immunoglubulins (1)

Immunological profiling (1)

Immunosuppressive (1)

Impact Event Score (1)

Impact of Event Scale-Revised (1)

Inactivated convalescent plasma (1)

Individualised Ayurveda (1)

Indomethacin (1)

Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration (1)

Information-only intervention (1)

Infusion IV of Mesenchymal Stem cells (1)

Inhaled Hypertonic ibuprofen (1)

Inhaled Supplemental Oxygen (1)

Inhaled beclomethasone (1)

Inhaled budesonide (1)

Inhaled nitric oxide gas (1)

Inhaled sedation (1)

Injection and infusion of LV-SMENP-DC vaccine and antigen-specific CTLs (1)

Injective placebo (1)

Insulin regimen (1)

Interferon beta 1a (1)

Interferon-Alpha2B (1)

Interferon-Beta (1)

Interferon-β 1a (1)

Interferon-β1a (1)

Interleukin-1 receptor antagonist (1)

Intermediate dose thromboprophylaxis (1)

Intermittent prone positioning instructions (1)

Internet-based guided self-help based on CBT principles (1)

Internet-based self-help (1)

Internet-based self-help after 3 weeks (1)

Internet-delivered cognitive behavior therapy (ICBT) for dysfunctional worry related to the Covid-19 pandemic (1)

Intervention program (1)

Interview by psychologists (1)

Intraosseous access (1)

Intravenous Immunoglobulin (1)

Intravenous access (1)

Intravenous drug (1)

Intravenous saline injection (Placebo) (1)

Intravenous sedation (1)

Invasive mechanical ventilation (1)

Isoprinosine (1)

Isotonic saline 0.9% (1)

Isotretinoin Only Product in Oral Dose Form (1)

Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment (1)

Ivermectin (IVM) (1)

Ivermectin + Doxycycline + Placebo (1)

Ivermectin + Placebo (1)

Ivermectin 6 MG Oral Tablet (2 tablets) (1)

Ivermectin Oral Product (1)

Ivermectin plus Nitazoxanide (1)

JNJ-53718678 (1)

KIR phenotype evaluation (1)

Kerecis Oral and Nasal Spray (1)

Ketogenic diet (1)

LSALT peptide (1)

Laboratory Analyses (1)

Laboratory Biomarker Analysis (1)

Lactated ringer's solution or sterile saline (1)

Lactoferrin (Apolactoferrin) (1)

Leflunomide (1)

Let It Out (LIO)-C (1)

Levamisole and Isoprinosine (1)

Levamisole and isoprinosine (1)

Liberase Enzyme (Roche) (1)

Linagliptin (1)

Linagliptin 5 MG (1)

Liquid Peanut Extract (1)

Liver injury (1)

Lopinavir / Ritonavir Pill (1)

Lopinavir / Ritonavir plus Ribavirin (1)

Lopinavir / ritonavir tablets combined with Xiyanping injection (1)

Lopinavir / ritonavir, alpha-interferon nebulization,Abidor Hydrochloride (1)

Lopinavir 200Mg/Ritonavir 50Mg Tab (1)

Lopinavir and Ritonavir Tablets (1)

Lopinavir and ritonavir (1)

Lopinavir/ Ritonavir Oral Tablet (1)

Lopinavir/Ritonavir (1)

Lopinavir/ritonavir 400 mg/100 mg (1)

Lopinavir/ritonavir treatment (1)

Low Dose Radiation Therapy (1)

Low Dose Radiotherapy (1)

Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule (1)

Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule (1)

Low dose CT (1)

Low molecular weight heparin (1)

Low nitrite/NDMA meals (1)

Low or upper respiratory tract sample (1)

Low-dose Chest CT (1)

Low-dose chloroquine (1)

Lucinactant (1)

Lung CT scan analysis in COVID-19 patients (1)

Lung Function tests (1)

Lung Low Dose Radiation (1)

Lung impedance technique (1)

MANAGEMENT OF COVID-19 (1)

MRx-4DP0004 (1)

MSC Treatment (1)

MSCs-derived exosomes (1)

MSTT1041A-matched Placebo (1)

MVA-MERS-S_DF1 - High Dose (1)

MVA-MERS-S_DF1 - Low Dose (1)

Machine learning model (1)

Macrolide administered for 3-5 days (1)

Macrolide administered for up to 14 days (1)

Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol) (1)

Masimo, LidCO (1)

Matched Placebo (1)

Matched Placebo Hydroxychloroquine (1)

Matching Placebo (1)

Matching placebo (1)

Matrix-M Adjuvant (1)

Measles-Mumps-Rubella Vaccine (1)

Mechanical Trombectomy (1)

Medical Mask (1)

Medical Ozone procedure (1)

Medical/surgical mask (1)

Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule (1)

Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule (1)

Mefloquine + azithromycin + / - tocilizumab (1)

Melatonin 2mg (1)

MenACWY vaccine (1)

MenACWY vaccine + boost (1)

Meplazumab for Injection (1)

Merimepodib (1)

Mesenchymal cells (1)

Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF) (1)

Mid-dose chloroquine (1)

Mindfulness + Compassion Intervention (MC) (1)

Mindfulness Alone (MO) Intervention (1)

Mindfulness session(s) (1)

Mindfulness-based "STOP touching your face" practice (1)

MinnRAP Peer Support Program (1)

Minocycline (1)

Modified Rankin score (1)

Monitoring Visit - Baseline (1)

Monitoring Visit - Week 4 (1)

Monitoring Visit - Week 8 (1)

Montelukast 10mg (1)

Montelukast Oral Granules (1)

Morning pranayama (1)

Moxifloxacin or Levofloxacin (1)

Multifrequency Bioimpedance Spectroscopy (1)

Multiple Doses of Anti-SARS-CoV-2 convalescent plasma (1)

Muscle ultrasound (1)

MuscleSound Ultrasound (1)

N-acetylcysteine (1)

N-acetylcysteine+ Fuzheng Huayu Tablet (1)

N-acetylcysteine+Placebo (1)

N95 Respirator (1)

N95 respirator (1)

NA (no intervention) (1)

NHANES smell and taste tests (1)

NIO® (Intraosseous access) (1)

NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells (1)

NO intervention planned due to the observational study design - only a diagnostic testing (1)

NO intervention planned due to the observational study design only a diagnostic testing (1)

NO-Immunosuppressive (1)

NP-120 (Ifenprodil) (1)

NSS Saline Placebo (1)

NaCl Solution (1)

Nafamostat Mesilate (1)

Nafamostat Mesylate (1)

Nasal Irrigation (1)

Naso pharyngeal swab (1)

Nasopharyngeal Swab (1)

Natural Honey (1)

NestaCell® (1)

Neutral writing control (1)

New QIAstat-Dx fully automatic multiple PCR detection platform (1)

New screening strategy (1)

Newsfeed function (1)

Next generation Sequencing (NGS) analysis (1)

Nicotinamide riboside (1)

Nigella Sativa / Black Cumin (1)

Nigella sativa (1)

Nintedanib 150 MG (1)

Nitazoxanide 500 MG (1)

Nitazoxanide 500Mg Oral Tablet (1)

Nitazoxanide Tablets (1)

Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation (1)

Nitric Oxide delivered via LungFit™ system (1)

Nivolumab Injection (1)

No intervention (survey study for medical doctors). (1)

No intervention - exposure is to COVID-19 (1)

No intervention, observational study (1)

No special intervention (1)

Non Extracorporeal Membrane Oxygenation (1)

Non applicable (1)

Non invasive visual acuity testing (1)

Non-Interventional (1)

Non-convalescent Plasma (control plasma) (1)

Non-convalescent fresh frozen plasma (Standard plasma) (1)

Non-interventional (1)

Non-invasive cardiac imaging (1)

Normal (9%) Saline (1)

Normal Saline (1)

Normal Saline 0.9% (1)

Normal Saline Infusion + standard of care (1)

Normobaric oxygen therapy (1)

Novel laser inferometry test for CORONA virus (1)

Nutrition support (1)

Observation (1)

Observation of behavior and COVID-19 infection will be conducted. (1)

Observation of patients with known, suspected, or at risk for COVID-19 infection (1)

Observation only (1)

Observational (registry) (1)

Observational Study (1)

Observational only (1)

Observational study (1)

Observational study only (1)

Octagam 10% (1)

Odd/Even birth year intervention groups (1)

Olfactory retraining (1)

Olokizumab 64 mg (1)

Omeprazole 20mg (1)

Online Questionnaire (1)

Online survey (1)

Only Standard Treatment (1)

Ophthalmologic exam (1)

Optical Coherence Tomography (OCT) (1)

Oral 25-Hydroxyvitamin D3 (1)

Oral fluid swab (1)

Oral placebo (1)

Oral-B Mouth Sore mouthwash (1)

Organicell Flow (1)

Oropharyngeal Swab (1)

Other drugs (1)

Others(No intervention) (1)

Outpatient MRI (1)

Oxygen Therapy (1)

Oxygen-ozone therapy, probiotic supplementation and Standard of care (1)

Ozone auto-hemotherapy (1)

P2Et (Caesalpinia spinosa extract) (1)

PCL COV05 - COVID 19 Ag Rapid FIA test (Rapid Antigen Test) (1)

PD-1 blocking antibody+standard treatment (1)

PHQ-9 (9-item Patient Health Questionnaire) (1)

PLACEBO GROUP (1)

PROTECTIVE VENTILATION (1)

PSS (Perceived Stress Scale) (1)

Pacebo: Calcium citrate (1)

Pandemic control measures (1)

Paracetamol (1)

Partially HLA-matched Virus Specific T cells (VSTs) (1)

Passed infection of SARS-CoV-2 (1)

Pathogen-specific aAPC (1)

Patient Status Engine (1)

Patient management suffering of coronavirus infection (1)

Patient sampling (1)

Patient-centred advice on Telephone Consultation in TB Patients: (1)

Patients admitted to Intensive Care Unit with SARS-CoV2 (1)

Patients with the treatment agains COVID19 (1)

Peer Resilience Champion (1)

Peginterferon Lambda-1a (1)

Peginterferon lambda alfa-1a subcutaneous injection (1)

Pegylated interferon lambda (1)

Pembrolizumab (MK-3475) (1)

Percutaneous Coronary Revascularization for STEMI (1)

Performing routine care (clinical and paraclinical tests) (1)

Personalized health education (1)

Phosphate buffered saline Placebo (1)

Photobiomodulation (1)

Physical Exam (1)

Physical Therapy (1)

Physical exercise (1)

Physiological serum (1)

Physiotherapy (1)

Piclidenoson (1)

Piperacillin-tazobactam (1)

Piperacillin/tazobactam (1)

Placebo (PBO) (1)

Placebo (Plasma-Lyte 148) (1)

Placebo + Placebo (1)

Placebo 250 cc 24 hours continuous infusion for 15 days (1)

Placebo Administration (1)

Placebo Comparator (1)

Placebo Glycerin SLIT (1)

Placebo PBMT/sMF (1)

Placebo Vaccine (1)

Placebo for Azithromycin (1)

Placebo for Hydroxychloroquine (1)

Placebo of Hydroxychloroquine (1)

Placebo of LPV/r Tablets (1)

Placebo of excipient(s) will be administered (1)

Placebo on a 0- and 14-day schedule (1)

Placebo on a 0- and 28-day schedule (1)

Placebo oral (1)

Placebo plus standard preventive measures (1)

Placebo solution (1)

Placebo to match adalimumab (1)

Placebo: Emtricitabine/tenofovir disoproxil Placebo (1)

Placebo: Hydroxychloroquine (1)

Plaquenil 200Mg Tablet (1)

Plasma Donation (1)

Plasma exchange (1)

Plasma from COVID-19 convalescent patient (1)

Plasma from a volunteer donor (1)

Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19 (1)

Pleth variability index (1)

Plitidepsin 1.5 mg/day (1)

Plitidepsin 2.0 mg/day (1)

Plitidepsin 2.5 mg/day (1)

Point of care ultrasound (1)

Point-of-Care Ultrasonography (POCUS) (1)

Point-of-care test for SARS-CoV-2 (1)

Polysomnography (1)

Postpartum women under investigation for Coronavirus or diagnosed with COVID-19 (1)

Postural Positioning (1)

Povidone-Iodine 0.5% (1)

Povidone-Iodine 2% (1)

Powered Air purifying respirator (1)

Practice details (1)

Pre_dinner pranayama (1)

Pre_lunch pranayama (1)

Prediction Market (1)

Pregnant women under investigation for Coronavirus or diagnosed with COVID-19 (1)

Premier Biotech COVID-19 IgG/IgM Rapid test Cassette (1)

Presatovir placebo (1)

Prevalence of COVID-19 (1)

Prone Positioning (1)

Prone Positioning (PP) (1)

Prone position ventilation (1)

Prone positioning (PP) (1)

Prospective oberservational registry (1)

Prototype swab (1)

Psychiatric counseling (1)

Psycho-Social Questionnaire (1)

Psychological and physical rehabilitation based humanistic care (1)

Public Health England Gold Standard (1)

Pulmonary Physiotherapy Techniques (1)

Pulmonary and Motor Rehabilitation (1)

Pulmonary function tests (1)

Pulmonary ultrasound (1)

Pulse oximetry (1)

Pyridostigmine Bromide (1)

Q-NRG Metobolic Cart Device (1)

Qualitative interviews (in 40 patients : 20 with COVID-19 and 20 without COVID-19) (1)

Quality of Life (1)

Quantitative IgG Test (1)

Quantitative analysis of SARS-CoV-2 antibodies (1)

Quercetin Prophylaxis (1)

Quercetin Treatment (1)

Questionnaire by phone call (1)

Questionnaire to study the psychological impact of confinement (1)

Questionnaire with precaution information (1)

Questionnaires (1)

Questionnaires for specific phobia (1)

Questionnaires on psychological quality of life (1)

Questionnaires, spirometry (1)

Quick Defense (1)

RBT-9 (90 mg) (1)

RIA-device (Remote Investigation and Assessment) (1)

RPH-104 80 mg (1)

RT PCR SARS-CoV-2 (1)

RT-PCR Covid-19 (1)

RT-PCR SARS-Cov2 (1)

Radiation therapy (1)

Radiological Detection (1)

Ramipril 2.5 MG Oral Capsule (1)

Random Donor Plasma (1)

Rapid detection test (1)

Rapid diagnostics using Anyplex TMII RV16 Detection (1)

Rapid molecular test (1)

Rarefaction (1)

Ravulizumab (1)

Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) (1)

Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid (1)

Recombinant Human Interferon α2b Spray (1)

Recombinant Interferon Alfa-2b (1)

Recombinant S protein SARS vaccine (1)

Recombinant human alkaline phosphatase (1)

Recombinant human angiotensin-converting enzyme 2 (rhACE2) (1)

Recombinant human interferon α1β (1)

Recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (1)

Recombinase aided amplification (RAA) assay (1)

Registery Data Collection (1)

Relation between frailty and clinical outcomes in elderly patients with COVID-19. (1)

Remote Cognitive Behavioral Therapy for Insomnia (1)

Remote consultation (1)

Reporting of anosmia, ageusia and other clinical symptoms (1)

Respiratory symptoms, symptoms of anxiety and depression, and post-traumatic stress screening (1)

Resveratrol (1)

Retrospective case-control analysis (1)

Retrospective data collection (1)

Reverse-transcription polymerase chain reaction (RT-PCR) (1)

Rintatolimod (1)

Risk factors (1)

Risk of MERS infection (1)

Ritonavir+Oseltamivir (1)

Rivaroxaban 2.5 MG (1)

RoActemra iv (1)

RoActemra sc (1)

Routine Oral Care and Analgesia (1)

Routine standard of care (1)

Ruxolitinib 5 MG (1)

Ruxolitinib administration (1)

Ruxolitinib plus simvastatin (1)

SAMBA II (Diagnostic for the Real World) (1)

SARS-CoV-2 IgG Antibody Testing Kit (1)

SARS-CoV-2 PCR (1)

SARS-CoV-2 diagnostic rapid test (1)

SARS-CoV-2 non-immune Plasma (1)

SARS-CoV-2 plasma (1)

SARS-CoV-2 questionnaire survey (1)

SARS-CoV-2 rS (1)

SARS-CoV-2 viral composition (1)

SARS-CoV-2-test (1)

SARS-CoV2 Infection (1)

SARS-CoV2 serum antibody testing (1)

SARS-Cov-2 infection (1)

SARS-Cov2 testing (1)

SARSCoV2 Convalescent Plasma (1)

SCB-2019 with AS03 adjuvant (1)

SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant (1)

SF12, EQ-5D-5L and work status standardized quantitative assessments (1)

SLEDD with a L-MOD (1)

SMS message support (1)

SPEQ (Specific Psychotic Experiences Questionnaire) - Paranoia and Grandiosity Subscales (1)

SPIN-CHAT Program (1)

STC-19 score (1)

Saline Control (1)

Saline Nasal Irrigation (1)

Saline containing 1% Human serum albumin（solution of MSC） (1)

Saline with Baby Shampoo Nasal Irrigation (1)

Sample Collection/Performance Evaluation (A) (1)

Sample Collection/Performance Evaluation (B) (1)

Sample collection (1)

Sampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine) (1)

Sampling salivary (1)

Sarilumab Prefilled Syringe (1)

Sarilumab SAR153191 (1)

Sars-Cov2 serology (1)

Satisfaction evaluation (1)

Scanning Chest X-rays and performing AI algorithms on images (1)

Schirmer Test I (1)

Secukinumab 150 MG/ML Subcutaneous Solution [COSENTYX] (1)

Self-Help Therapy (1)

Self-guided exercises (1)

Self-help booklet (1)

Self-prone position recommendation (1)

Self-questionnary (1)

SensiumVitals wearable sensor (1)

Seraph®-100 Microbind® Affinity Blood Filter (1)

Serologic SARS-CoV-2 screening (1)

Serological analyses to be lead on a pre-existing biobank (1)

Serological screening for IgG and IgM antibodies against COVID-19 (1)

Serology for Covid-19 (1)

Serum SARs COV 2 IGg screening in health care workers (1)

Serum testing (1)

Sevoflurane (1)

Shock-dependent hydrocortisone (1)

Simvastatin (1)

Single fraction whole lung radiotherapy (1)

Sirolimus 1 MG/ML (1)

Social media & news consumption (1)

Sodium Chloride 9mg/mL (1)

Sodium Nitrite (1)

Software Messaging (1)

Sputum and blood sampling (1)

Sputum sample (1)

Staff Wellbeing Centres (1)

Stamaril (live attenuated yellow fever vaccine) (1)

Standar medical treatmen (1)

Standar of care (1)

Standard (specific) therapy for COVID-19 (1)

Standard 12-lead ECG, NT-proBNP, echocardiography (1)

Standard Care Therapy (1)

Standard Donor Plasma (1)

Standard Mask (1)

Standard Of Care (SOC) (1)

Standard Plasma (1)

Standard Plasma (FFP) (1)

Standard Public Health measures (1)

Standard administration of oxygen flow (1)

Standard medical care (1)

Standard of Care (Intravenous access) (1)

Standard of Care (SoC) (1)

Standard of Care thromboprophylaxis (1)

Standard of care (SOC) (1)

Standard of care for SARS-CoV-2 infection (1)

Standard of care management (1)

Standard of care therapies (1)

Standard of care therapy (1)

Standard of care treatment (1)

Standard of care. (1)

Standard screening strategy (1)

Standard supportive care (1)

Standard therapy (1)

Standard therapy for COVID-19 according to the stablished hospital protocols. (1)

Standard therapy of COVID-19 (1)

Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin inhalation (1)

Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection (1)

Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection combined with Dalargin inhalation (1)

Standard therapy recommended by the Ministry of Health of the Russian Federation. (1)

Standard treatment according to the Clinical protocols (1)

Standard-of-care (1)

Standard-of-care treatment (1)

Standardised questionnaires (1)

Standardized crisis management and coping protocol plan toward Coronavirus disease 2019 (COVID-19) (1)

Standards of Care (1)

Stem Cell Educator-Treated Mononuclear Cells Apheresis (1)

Sterile Normal Saline for Intravenous Use (1)

Sterile Water for Injection (1)

Stool collection (1)

Stool collection or fecal swab (1)

Streptokinase (1)

Study Group (1)

Study of immune-mediated mechanisms in patients tested positive for SARS-CoV-2 (1)

Sulfonatoporphyrin(TPPS) plus Sunlight exposure. (1)

Support treatment (1)

Surgery: Dynamic Hip Screw, hemiarthroplasty, hip replacement, intramedullary nail (1)

Surgical facial mask (1)

Survey and Questionnaire (1)

Susceptibility to infection (1)

Suspension or Maintenance of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors (1)

Swallowing evaluation with the EAT-10 and the volume-viscosity swallowing test (V-VST) (1)

Symptom and Exposure Surveys (1)

Symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations) (1)

Symptoms questionnare (1)

Systemic indirect endovenous ozone therapy (1)

T-cell receptor (TCR) repertoire (1)

TAVR or SAVR (1)

TCM prescriptions (1)

TLRs activation measurement (1)

Taking biological samples (1)

Taste and olfactory function evaluation (1)

Tele-interventions related to diabetes management and mental well-being (1)

Tele-medicine platform (1)

Teleconsultation either by phone or by computer consultation (1)

Telehealth monitoring (1)

Telemedicine to remote outpatient visit in bariatric patient (1)

Telephone follow-up (1)

Telephone interview (1)

Telephone survey (1)

Telephonic medical visit (1)

Telerehabilitation-Based (1)

Telmisartan 40mg (1)

Telmisartan arm will receive 80 mg Telmisartan twice daily plus standard care. (1)

Ten-days oseltamivir (1)

Tested for SARS-CoV-2 (regardless of the result) (1)

Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals (1)

Tetrandrine (1)

Thalidomide (1)

The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: (1)

The Vie Scope laryngoscope (1)

The standard Macintosh laryngoscope (1)

Therapeutic Anticoagulation (1)

Therapeutic Plasma Exchange (1)

Therapist Guided E-Therapy (1)

Therapy Intervention (1)

There is no intervention (1)

There is no intervention in this study (1)

Thermography (1)

Thiazide or Thiazide-like diuretics (1)

This is an online survey with no intervention. (1)

Thoracic CT Scan (1)

Throat swab (1)

Throat swab and/or nasopharyngeal swab (1)

Throat swab sample for measuring current infection with SARS-CoV-2 (1)

Thrombin Generation Assay (TGA) (1)

Thrombin generation test assay (1)

Thrombomodulin Modified Thrombin Generation Assay (TGA-TM) (1)

Thromboprophylaxis (1)

Thymosin+standard treatment (1)

Tinzaparin or unfractionated heparin (1)

Tirofiban Injection (1)

To assess for development of IgG antibodies against SARS-CoV2 (1)

Tociliuzumab (1)

Tocilizumab 180 MG/ML (1)

Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA] (1)

Tocilizumab Injection (1)

Tocilizumab Prefilled Syringe (1)

Tofacitinib (1)

Tofacitinib 10 mg (1)

Toraymyxin PMX-20R (PMX Cartridge) (1)

Tracheotomy (1)

Tradipitant (1)

Traditional Chinese Medicine Prescription (1)

Transcutaneous Auricular Vagus Nerve Stimulation (1)

Transfusion of COVID-19 convalescent plasma (1)

Transfusion of SARS-CoV-2 Convalescent Plasma. (1)

Transfusion of standard Plasma. (1)

Transpulmonary thermodilution (1)

Treatment and prophylaxis (1)

Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days : (1)

Treatment with Dexmedetomidine (1)

Trimethoprim Sulfamethoxazole (TMP/SMX) (1)

Two doses of high dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule (1)

Two doses of high dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule (1)

Two doses of high dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 (1)

Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 (1)

Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule (1)

Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule (1)

Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 (1)

Two doses of placebo at the emergency vaccination schedule (1)

Two doses of placebo at the routine vaccination schedule (1)

Two doses of placebo at the schedule of day 0,28 (1)

Tympanic Temperature (1)

ULTRAPROTECTIVE VENTILATION (1)

UNIKINON (Chloroquine phosphate) 200mg tablets (1)

UTTR1147A-matched Placebo (1)

Ulinastatin (1)

Ultra-Low-dose radiotherapy (1)

Ultrasound lung imaging as part of FAST+ evaluation (1)

Umbilical Cord Mesenchymal Stem Cells (1)

Umbilical cord Wharton's jelly-derived human (1)

Unfractionated Heparin IV (1)

Unfractionated heparin SC (1)

Unsupervised exercise (1)

Urine sample (1)

Use of social media during COVID-19 (1)

Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures (1)

Usual antibiotic treatment (1)

Usual care positioning with no instructions (1)

VRC-SRSDNA015-00-VP (1)

Valsartan (Diovan) (1)

Vazegepant (BHV-3500) (1)

Vehicle Control (1)

Venepuncture (1)

Ventil - a gas flow divider (1)

Video based aerobic exercise (1)

Video based exercise (1)

Video-Based (1)

Views and experiences of health care professionals working in intensive care units during the COVID-19 pandemic (1)

Viral Specific T-cells (VSTs) (1)

Virtual-Care Cognitive Behavioural Therapy (1)

VitalConnect Vital Sign Patch (1)

Vitamin Super B-Complex (1)

Viusid and Asbrip (1)

VivaDiag™ COVID-19 lgM/IgG Rapid Test (1)

Volatile Organic Compounds analysis (1)

WFI 5% glucose (1)

WHO recommendations (waiting condition) (1)

Web + text smoking cessation intervention (1)

Web Based Survey (1)

Web application users (1)

Web-based psychosocial peer-to-peer support (1)

Weekly Assessment (1)

Wharton's jelly derived Mesenchymal stem cells. (1)

Whole Exome Sequencing (1)

Whole Genome Analysis (1)

Women receiving extra remembering by healthcare (1)

XCEL-UMC-BETA (1)

Xiyanping injection (1)

Yin Hu Qing Wen Granula(low does) (1)

Yinhu Qingwen Granula (1)

Zanubrutinib (1)

Zaritt Burden Interview (1)

Zilucoplan® (1)

Zinc (Placebo) (1)

Zinc Gluconate (1)

Zithromax Oral Product (1)

[TIMP-2]*[IGFBP-7] (1)

a specifically designed self-administered questionnaire (1)

acute kidney injury (1)

additional blood tubes (1)

all treatment about COVID-2019 (1)

allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC) (1)

alpha one antitrypsin inhalation (1)

alveolar recruitment (1)

amoxicillin/clavulanate (1)

artus Influenza A/B RT-PCR Test (1)

azithromycin (1)

azoximer bromide (1)

bacTRL-Spike (1)

bidirectional oxygenation mouthpiece (1)

biological samples collection (1)

blood samples (1)

blood sampling for biobank (1)

captopril 25mg (1)

care modalities (1)

chlorine dioxide 3000 ppm (1)

chloroquine (1)

cholecalciferol 200,000 IU (1)

cholecalciferol 50,000 IU (1)

collection of biological samples (1)

conjunctival RT PCR (1)

conjunctival swab (1)

consultation (1)

convalescent plasma application to SARS-CoV-2 infected patients (1)

convalescent plasma from recovered COVID 19 donor (1)

conventional management of patients (1)

conventional oxygen (1)

corticosteroid nasal irrigation (1)

covid-19 positive pregnant women (1)

current IPAC-UHN PPE (1)

daily syndromic surveillance (1)

evaluation of skin microvascular flow and reactivity (1)

exercise brochure (1)

favipiravir (1)

favipiravir tablets+chloroquine phosphatetablets tablets (1)

fsfi survey (1)

further processing of health data (1)

gammaCore® Sapphire (non-invasive vagus nerve stimulator) (1)

global survey (1)

high flow nasal cannula (HFNC) (1)

high-titer anti-Sars-CoV-2 plasma (1)

hospitalized children with Covid19 (1)

human cord tissue mesenchymal stromal cells (1)

hydroxychloroquine + azithromycin (1)

hydroxychloroquine in combination with camostat mesylate (1)

hydroxychloroquine placebo (1)

hydroxychloroquine sulfate 200 MG (1)

hyper immunoglobulins containing anti-Corona VS2 immunoglobulin (1)

hyperbaric oxygen therapy (HBOT) (1)

hyperimmune plasma (1)

iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System (1)

identify SARS-CoV-2 infection by serology (1)

impliminting Online Distance Learning (1)

indirect calorimetry (1)

intradermal injection of BCG Vaccine (1)

isocaloric/isonutrigenous ONS (1)

laboratory biomarkers (1)

less-frequency hemodialysis (1)

lopinavir/ritonavir (1)

lopinavir/ritonavir group (1)

lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate (1)

lung ultrasound (1)

lung ultrasound (LUS) (1)

mHealth Assessments (1)

mRNA in urine test (1)

measurement of circulating sFlt1 concentration (1)

mechanical ventilation (1)

meplazumab for injection (1)

mesenchymal stem cells (1)

methylprednisolone therapy (1)

modification of the planned therapeutic management (1)

modified IPAC-UHN PPE (1)

molecular testing for virus RNA using RT-PCR (1)

monthly serologic IgM/G test (1)

mouthrinse with bêta-cyclodextrin and citrox (1)

mouthrinse without bêta-cyclodextrin and citrox (1)

muscle ultrasound (1)

nasal pharyngeal (NP) swab samples (1)

nasopharyngeal Covid 19 RT-PCR (1)

nasopharyngeal swab (1)

newborns from covid 19 positive mothers (1)

no intervention-mechanistic study (1)

no interventional study (1)

non interventional (1)

non-RAS blocking antihypertensives (1)

non-contact magnetically-controlled capsule endoscopy (1)

nosocomial infection/hospital acquired infection (1)

observation (1)

observation of covid 19 pneumonia (1)

olfactory and gustatory tests (1)

oral nutrition supplement (ONS) enriched in eicosapentaenoic acid, gamma-linolenic acid and antioxidants (1)

oxygen treatment (1)

oxyhydrogen (1)

pathogen reduced SARS-CoV-2 convalescent plasma (1)

patients COVID 19 (1)

patients receiving nasal high flow (1)

performance evaluation study of RealDetect RT-PCR Kit for COVID-19 detection (1)

peripheral blood draw (1)

photobiomodulation and photodynamic therapy (1)

pirfenidone (1)

placebo (hartmann plus albumine) (1)

placebo for clazakizumab (1)

plasma hyperimmune (1)

plasma therapy using convalescent plasma with antibody against SARS-CoV-2 (1)

prednisolone (1)

prone position (1)

quesionnair (1)

questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality (1)

quetionnary (1)

rapid salivary test (1)

recombinant human interferon Alpha-1b (1)

research specific blood sample (1)

risk factors (1)

samling of oropharynx and nasopharynx (1)

self-administered structured questionnaire (1)

serological test (1)

serum chemistry analysis (1)

serum inflammatory biomarkers (1)

severe covid-19 pneumonia with ET (1)

smell household Items (1)

sodium chloride 0.9% (1)

standard medical treatment (1)

standard of care (1)

standard operating procedures (1)

standard procedure (1)

standard protocol (1)

standard treatment (1)

standardized Lung Ultrasound (LUS) examination (1)

survey work (1)

systemic treatment (1)

telehealth applications (1)

thalidomide (1)

this study is non- interventional (1)

thromboprofylaxis protocol (1)

thromboprophylaxis with low-molecular-weight heparin or fondaparinux (1)

thymosin alpha 1 (1)

trimethoprim/sulfamethoxazole (1)

turkish physicians (1)

use and exposure to disinfectants during the coronavirus pandemic (1)

vaccine BCG (1)

vaccine candidate MVA-MERS-S (1)

ventilatory support with oxygen therapy (1)

washed microbiota transplantation (1)

ıt will be compared pain, sleep, fatigue, physical activity level and quality of life and questioning exercise habits before and after the covid-19 outbreak in patients with Behçet and FMF. (1)

γ-Globulin (1)

Covid 19 Research using Clinical Trials (Home Page)

Sample collectionWiki

Developed by Shray Alag

Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (1)

	Name (Synonyms)	Correlation
drug1671	telehealth applications Wiki	1.00

Correlated MeSH Terms (2)

	Name (Synonyms)	Correlation
D045169	Severe Acute Respiratory Syndrome NIH	0.06
D018352	Coronavirus Infections NIH	0.05

Correlated HPO Terms (0)

	Name (Synonyms)	Correlation

There is one clinical trial.

Clinical Trials

1 Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals

The purpose of this study is to learn more about infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people know this virus by the name "coronavirus." It can cause the disease called COVID-19. The information gained from the study will be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines and treatments by allowing researchers to determine the difference between the body's immune response to natural SARS-CoV-2 infection and immunization with a SARS-CoV-2 vaccine.

NCT04403880 SARS-CoV-2 COVID-19 Other: Sample collection

Primary Outcomes

Description: Measured by peptide microarray

Measure: Humoral responses to peptide antigens derived from SARS-CoV-2 structural proteins and regions of the spike protein not present in vaccines

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by binding antibody multiplex assay (BAMA)

Measure: SARS-CoV-2-specific antibody binding response rate

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by binding antibody multiplex assay (BAMA)

Measure: SARS-CoV-2-specific antibody binding response magnitude

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by binding antibody multiplex assay (BAMA)

Measure: SARS-CoV-2-specific antibody binding response epitope specificity

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by neutralizing antibody assay (NAb)

Measure: SARS-CoV-2-specific antibody neutralization response rate

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by neutralizing antibody assay (NAb)

Measure: SARS-CoV-2-specific antibody neutralization response magnitude

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by neutralizing antibody assay (NAb)

Measure: SARS-CoV-2-specific antibody neutralization response epitope specificity

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by antibody-dependent cellular cytotoxicity assay (ADCC)

Measure: SARS-CoV-2-specific Antibody-Dependent Cellular Cytotoxicity (ADCC) response rate

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by antibody-dependent cellular cytotoxicity assay (ADCC)

Measure: SARS-CoV-2-specific Antibody-Dependent Cellular Cytotoxicity (ADCC) response magnitude

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by antibody-dependent cellular cytotoxicity assay (ADCC)

Measure: SARS-CoV-2-specific Antibody-Dependent Cellular Cytotoxicity (ADCC) response epitope specificity

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by flow cytometry

Measure: SARS-CoV-2-specific CD4+ and CD8+ T cell responses

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by flow cytometry

Measure: SARS-CoV-2-specific CD4+ and CD8+ T cell response rate

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by flow cytometry

Measure: SARS-CoV-2-specific CD4+ and CD8+ T cell response magnitude

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by flow cytometry

Measure: SARS-CoV-2-specific CD4+ and CD8+ T cell response functional profiling

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by phenotyping and monoclonal antibody isolation

Measure: SARS-CoV-2-specific memory B cell characterization

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Tabulated overall and by group

Measure: SARS-CoV-2-specific infection presentation, including clinical course, along with demographics and corresponding medical history of participants

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Secondary Outcomes

Description: Measured by real-time reverse transcription polymerase chain reaction (RT-PCR) assay

Measure: Detection of viral RNA in nasopharyngeal or nasal swab samples

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by binding antibody multiplex assay (BAMA)

Measure: Response rate of SARS-CoV-2-specific binding antibodies in nasal samples

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

Description: Measured by binding antibody multiplex assay (BAMA)

Measure: Response magnitude of SARS-CoV-2-specific binding antibodies in nasal samples

Time: Measured through participant's last visit at Month 0, 2, 4, or 12

No related HPO nodes (Using clinical trials)